MedPath

A study for measurement of Glycemic Index (GI) of two kinds of foods in adult males and females

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000037071
Lead Sponsor
TTC Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects routinely taking medicine or health food which may influence glucose metabolism (2) Subjects whose BMI exceeds 30.0 kg/m2 (3) Subjects whose blood glucose level exceeds 126 mg/dL (4) Subjects who have been pointed out as impaired glucose tolerance within 1 year (5) Subjects who are suspected as impaired glucose tolerance in preliminary examination (6) Subjects whose blood glucose level exceeds 110 mg/dL in glucometer on admission (7) Subjects planned to travel abroad during the study period (8) Subjects having possibilities for emerging allergy related to the current study (9) Subjects who drink much alcohol (10) Subjects who do excessive smoking (11) Subjects who donated blood (blood donation etc.) exceeding 200 mL within 1 month or 400 mL within 4 months (12) Subjects who have under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) (13) Subjects who have under treatment (e.g.,adiposity,hyperlipidemia, hypertension) that affects the evaluation of this study or medical history of serious illness for medication (14) Subjects whose values of physical measurement, physical examination and clinical laboratory are significantly different from the reference range (15) Subjects who may be pregnant or are pregnant, breastfeeding, or those who desire pregnancy during the study period (16) Subjects who have participated in other clinical study within the last one month or have plan to participate other clinical studies (17) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (18) Subjects who are judged as ineligible by the clinical investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath